Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
US8119112B2 · kind B2 · utility
8Cited by
11References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 3, 2008 |
| Grant date | Feb 21, 2012 |
| Priority date | — |
| Expiry date | Sep 3, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L12/143
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Ophthalmic compositions that comprise 0.1 ppm to 10 ppm of a cationic antimicrobial component selected from the group consisting of biguanides, polymeric biguanides, quaternium ammonium compounds and any one mixture thereof; 0.005 wt. % to 0.15 wt. % of hyaluronic acid; and 0.01 wt. % to 1.0 wt. % of an amphoteric surfactant of general formula I
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.